ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

The Assistance Fund Marks 100th Disease Program, Expands Support to People Living With Macular Degeneration

Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Macular Degeneration

ORLANDO, FLORIDA / ACCESS Newswire / September 23, 2025 / The Assistance Fund (TAF), an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of its 100th disease program, a new copay assistance program for people living with macular degeneration. The program is designed to help eligible individuals pay for their out-of-pocket medical costs for treatment, such as copays, coinsurance, and deductibles. Since its founding in 2009, TAF has helped over 210,000 children and adults access the treatment they need to stay healthy or manage a life-changing disease.

Macular degeneration is an eye condition where people, typically adults over the age of 50, struggle to see directly in front of them. The condition can develop in one eye or both eyes, leaving it difficult to see. Nearly 20 million Americans are living with the disease, which requires treatment to slow its progression.1

"For older adults, vision is about more than sight-it's about maintaining independence, connection, and dignity," said Danielle Vizcaino, President and CEO of The Assistance Fund. "As we commemorate the opening of our 100th disease program, I'm deeply grateful for the generosity of our donors, whose compassion makes it possible for people living with macular degeneration-and so many other life-changing conditions-to access the care they need and deserve."

"It's a profound honor to see The Assistance Fund launch its 100th program, a milestone that reflects our unwavering commitment to people living with life-changing diseases," said Linda Howard, Board Chair. "With this momentum, I am confident TAF will continue breaking down barriers to treatment and bringing hope to even more patients and families for years to come."

To learn more or determine eligibility for financial support, visit tafcares.org or call (833) 844-5366 to speak with a Patient Advocate.

A list of all the disease programs available from The Assistance Fund can be found on the website tafcares.org.

About The Assistance Fund

The Assistance Fund (TAF) is an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses. The Assistance Fund currently manages 100 disease programs, each of which covers all the FDA-approved medications that treat a specific disease named in the disease program. Since its founding in 2009, TAF has helped over 210,000 children and adults access the treatment they need to stay healthy or manage a life-changing disease. To learn more about The Assistance Fund, or for information on how to donate, please visit tafcares.org.

Media Contact

Margaret Figley
Senior Director of Communications
margaret.figley@tafcares.org

1Cleveland Clinic, "Macular Degeneration," https://my.clevelandclinic.org/health/diseases/15246-macular-degeneration, accessed September 2025.

.

SOURCE: The Assistance Fund (TAF)



View the original press release on ACCESS Newswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.